DSG2 and breast neoplasm: Since desmoglein 2 is expressed by both MDA-MB-231 and MCF-7 cells [69] and was shown to promote breast tumor growth, where its cleavage sensitizes cells to apoptosis, future studies will investigate if the observed FimH-dependent cytotoxicity is mediated by desmoglein 2 [70].